Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 974 clinical trials
Pentoxifylline in Diabetic Kidney Disease (PTXRx)

kidneys from damage due to diabetes and other diseases. "Pentoxifylline in Diabetic Kidney Disease" is a study to bee conducted in 40 VA hospitals across the nation to determine definitively whether or

diabetes
diabetic nephropathy
pentoxifylline
nephropathy
  • 42 views
  • 20 Jun, 2022
  • 16 locations
Atrasentan in Patients With IgA Nephropathy (ALIGN)

The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA nephropathy (IgAN) at risk of progressive

renal function
nephropathy
  • 47 views
  • 17 Jun, 2022
  • 119 locations
A Phase 2b Diabetic Kidney Disease Study

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects with Diabetic Kidney Disease

diabetic nephropathy
nephropathy
  • 456 views
  • 07 Jul, 2022
  • 88 locations
Aspirin to Target Arterial Events in Chronic Kidney Disease (ATTACK)

This study aims to find out whether people with chronic kidney disease [CKD] should take low dose aspirin to reduce the risk of first heart attack or stroke (cardiovascular disease [CVD]). CKD

stroke
proteinuria
glomerular filtration rate
chronic disease
primary prevention
  • 0 views
  • 25 Mar, 2022
  • 1 location
Chronic Kidney Disease at Northeast Taiwan: Biomarker and Multidisciplinary Care

CKD is a global endemic disease with increased comorbidities and mortality. The prevalence and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. Early diagnosis

nephropathy
Accepts healthy volunteers
renal failure
  • 4 views
  • 01 Mar, 2022
  • 1 location
Improving Medical Decision Making for Older Patients With End Stage Renal Disease (VIDEO-KD)

The overall objective of this study is to reduce the burden of chronic kidney disease (CKD) and its consequences for an aging U.S. population. To accomplish this, the investigators propose to

  • 1 views
  • 10 Mar, 2022
  • 8 locations
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients (APPLAUSE-IgAN)

maximally tolerated ACEi or ARB on reduction of proteinuria and slowing renal disease progression in primary IgA Nephropathy patients.

treatment regimen
fibrosis
proteinuria
nephropathy
adrenaline
  • 11 views
  • 11 Aug, 2022
  • 159 locations
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

cardiac event (MACE) in people with Chronic Kidney Disease (CKD) stages 4 or 5 or dialysis-dependent End Stage Kidney Disease (ESKD), and elevated cardiovascular (CV) risk, whilst maintaining an

dialysis
  • 2 views
  • 22 Dec, 2021
  • 34 locations
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (SANCTUARY)

The objectives of this study are to evaluate the safety and efficacy of ravulizumab administered by intravenous (IV) infusion compared to placebo and demonstrate proof-of-concept of the efficacy of terminal complement inhibition in participants with LN (LN Cohort) or IgAN (IgAN Cohort).

lupus
proteinuria
nephropathy
angiotensin
nephritis
  • 5 views
  • 22 Jul, 2022
  • 68 locations
Population-based Chronic Kidney Disease Cohort at Northern Taiwan

CKD is a global endemic disease with increased comorbidities and mortality. The prevalence and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. The prevalence of

  • 0 views
  • 23 Jan, 2021
  • 1 location